Edward Acosta
Overview
Explore the profile of Edward Acosta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Prasain J, Peng N, Acosta E, Moore R, Arabshahi A, Meezan E, et al.
Biomed Chromatogr
. 2007 Jan;
21(4):410-4.
PMID: 17221935
A highly sensitive and specific atmospheric pressure chemical ionization liquid chromatography-tandem mass spectrometry method was developed for serum pharmacokinetic studies of puerarin in rats. Chromatography was carried out on a...
12.
Boffito M, Acosta E, Burger D, Fletcher C, Flexner C, Garaffo R, et al.
Antivir Ther
. 2005 Jul;
10(4):469-77.
PMID: 16038472
The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (Pls)...
13.
Boffito M, Acosta E, Burger D, Fletcher C, Flexner C, Garaffo R, et al.
Antivir Ther
. 2005 May;
10(3):375-92.
PMID: 15918329
The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors and protease inhibitors provide a...
14.
Stringer J, Sinkala M, Goldenberg R, Vermund S, Acosta E
Lancet
. 2003 Aug;
362(9384):667.
PMID: 12944077
No abstract available.
15.
Gulick R, Hu X, Fiscus S, Fletcher C, Haubrich R, Cheng H, et al.
J Infect Dis
. 2002 Aug;
186(5):626-33.
PMID: 12195349
The 24-week extension of AIDS Clinical Trials Group Protocol 359, a study of human immunodeficiency virus (HIV)-infected, indinavir-experienced patients, was designed to study the durability of "salvage" treatment regimens. Patients...